Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2010

Sep 9, 2010

34983_dirs_2010-09-08_19a0cd3b-e283-4099-8e6e-1380c4f53bcb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-08-27

Reporting Person: DEMARTINI DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-08-27 Common Stock P 1400 $0.18 Acquired 1601400 Direct
2010-08-30 Common Stock P 23600 $0.18 Acquired 1625000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1600000 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant $0.2 2011-07-11 common stock (1500000) 1500000 Direct
Warrant $0.22 2010-12-24 common stock (50000) 50000 Direct
Stock Option $0.2 2011-07-20 common stock (6250) 6250 Direct
Stock Option $0.2 2015-01-20 common stock (100000) 106250 Direct

Footnotes

F1: Canadian Dollars